multilink biotinylated secondary antibodies (Biogenex)
90
Structured Review
Biogenex
multilink biotinylated secondary antibodies
Multilink Biotinylated Secondary Antibodies, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multilink+biotinylated+secondary+antibodies/biotinylated+secondary+multilink+antibody/pmc10984533-50-21-25
Average 90 stars, based on 1 article reviews
Multilink Biotinylated Secondary Antibodies, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multilink+biotinylated+secondary+antibodies/biotinylated+secondary+multilink+antibody/pmc10984533-50-21-25
Average 90 stars, based on 1 article reviews
multilink biotinylated secondary antibodies - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all- trans -retinoic acid Article Snippet: Slides were washed in Tris-buffered saline with 0.1% Tween-20 (TBST) and incubated with a 1:50 dilution of MultiLink biotinylated secondary antibodies ( Incubation:Article Title: Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma. Article Snippet: Aims: Extramedullary plasmacytoma (EMP) and multiple myeloma (MM) are both plasma cell (PC) tumours that are usually distinguished by clinical manifestations, but not by histopathological examination alone.. However, EMP may express B-cell markers, such as CD79a and CD20, and MM may express germinal centre B-cell (GCBC)-associated microRNAs, such as miR-93 and miR-181b.. Down-regulation of miR-30a or up-regulation of miR-223 is associated with the transition from GCBCs into PCs or memory B-cells, respectively. Staining:Article Title: Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma. Article Snippet: Aims: Extramedullary plasmacytoma (EMP) and multiple myeloma (MM) are both plasma cell (PC) tumours that are usually distinguished by clinical manifestations, but not by histopathological examination alone.. However, EMP may express B-cell markers, such as CD79a and CD20, and MM may express germinal centre B-cell (GCBC)-associated microRNAs, such as miR-93 and miR-181b.. Down-regulation of miR-30a or up-regulation of miR-223 is associated with the transition from GCBCs into PCs or memory B-cells, respectively. |